Joseph Rus

Joseph Rus

Direktor/Vorstandsmitglied bei BELLUS HEALTH
80 Jahre
Health Technology
Commercial Services
Distribution Services

Profil

Joseph Rus currently works at BELLUS Health, Inc., as Independent Director from 2009.
Mr. Rus also formerly worked at Shire BioChem, Inc., as President & Chief Executive Officer from 2001 to 2011, Shire Canada, Inc., as Chief Executive Officer, Merus Labs International, Inc., as Chairman from 2012 to 2013, Envoy Capital Group, Inc., as Director in 2011, Adaltis, Inc., as Director from 2001 to 2008, ViroChem Pharma, Inc., as Director, United Way of Canada, as Director, Centraide of Greater Montreal, as Director, Shire Italia SpA, as Director, Tanaud International BV, as Director, Shire Pharmaceuticals Mexico SA de CV, as Director, Glaxosmithkline Shire, Inc., as Director, 3829359 Canada, Inc., as Director, Shire Plc, as EVP & GM-International Operations from 2002 to 2008, and Shire Acquisition, Inc., as EVP-Market Alliance & New Market Development from 1999 to 2008.

Aktive Positionen von Joseph Rus

UnternehmenPositionBeginn
BELLUS HEALTH Direktor/Vorstandsmitglied 01.06.2009

Ehemalige bekannte Positionen von Joseph Rus

UnternehmenPositionEnde
MERUS LABS INTERNATIONAL INC Vorsitzender 09.07.2013
Vorstandsvorsitzender -
Direktor/Vorstandsmitglied 19.12.2011
Direktor/Vorstandsmitglied 02.10.2008
Corporate Officer/Principal 23.05.2008
Sehen Sie sich die Erfahrung von Joseph Rus im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

66

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Distribution Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Services

Miscellaneous

Health Technology

Health Technology

Glaxosmithkline Shire, Inc.

3829359 Canada, Inc.

  1. Börse
  2. Insiders
  3. Joseph Rus